Tricyclic Antidepressants: What They Are and When They Are Still Used
Last updated November 5, 2026
Key Takeaways
- Tricyclic antidepressants (TCAs) are an older antidepressant class, including amitriptyline, nortriptyline, clomipramine, doxepin, and desipramine. They work about as well as SSRIs for depression, but more people stop them because of side effects.
- TCAs are much more dangerous in overdose than SSRIs because they slow electrical conduction in the heart, which, along with side effects, is why they're no longer a first choice for depression.
- They're still used for specific jobs: nerve pain, low doses for irritable bowel syndrome, clomipramine for OCD, and low-dose doxepin for trouble staying asleep.
- Older adults, people with heart disease, and anyone at risk of overdose need extra caution, and pain guidelines recommend a screening ECG before starting a TCA, especially after age 40.
- If you or someone you love may have taken too much of a TCA, call 911 right away, even if they seem fine.
You may have heard a tricyclic described as an “old” antidepressant, maybe from a pharmacist, maybe from a parent who took one decades ago. Then a doctor suggests one for nerve pain or sleep, and you’re left wondering whether you’re getting yesterday’s medicine. That question deserves a straight answer.
Your nervous system passes signals using chemical messengers like norepinephrine and serotonin, and your nerve cells recycle those messengers through tiny reuptake pumps. Tricyclic antidepressants slow that recycling, which leaves more of the messenger active between cells. They also block several other receptors, and that lack of precision is what explains both their power and their side effects.
Tricyclics, or TCAs, were developed in the 1950s and were among the main antidepressant treatments for decades. Their track record is strong. In a 2018 network meta-analysis of 522 trials, every one of 21 antidepressants beat placebo, and the tricyclic amitriptyline had the largest effect of all. The results are real, and the science is well established.
But effectiveness is only half of the decision, and at Siggy we think a medication’s safety margin and side effect load deserve as much attention as its response rate.
That’s why modern psychiatry uses tricyclics with more precision: as second-line options for depression and as targeted, often low-dose treatments for nerve pain, irritable bowel syndrome, OCD, and insomnia. Matching the drug, the dose, and the monitoring to the person is what makes a tricyclic reasonable today. The difference comes from pharmacology and outcome data, and it shapes who should take one.
What This Page Covers
- What Are Tricyclic Antidepressants?
- Why Did SSRIs Replace Tricyclics as the First Choice?
- When Are Tricyclics Still Used Today?
- What Side Effects Do Tricyclics Cause?
- Why Is a Tricyclic Overdose So Dangerous?
- Who Should Be Careful With Tricyclics?
- How Siggy Fits In
- The Bottom Line on Tricyclic Antidepressants
- Start Your Anonymous Intake
What Are Tricyclic Antidepressants?
Tricyclic antidepressants get their name from their three-ring chemical structure. The class includes amitriptyline, nortriptyline, imipramine, desipramine, clomipramine, doxepin, and a few others.
According to a 2007 pharmacology review, TCAs grew out of antihistamine research in the 1950s, and blocking histamine remains their most potent shared property. They also block norepinephrine reuptake, and some block serotonin reuptake too. Clomipramine is the only one with clinically meaningful action on both.
Each TCA has a different balance of these effects, so they aren’t interchangeable. Here’s how five common ones compare.
| Medication | Common Uses Today | Side Effect Profile |
|---|---|---|
| Amitriptyline | Nerve pain, IBS, depression | Very sedating, strongly anticholinergic |
| Nortriptyline | Depression, nerve pain | Milder than amitriptyline, blood levels guide dosing |
| Clomipramine | OCD, depression | Typical TCA effects, rare seizures |
| Doxepin | Low doses for staying asleep | Strong antihistamine, sedating |
| Desipramine | Depression | Least anticholinergic in the class |
The pharmacology review above is the source for the side effect differences, and the treatment sections below cover the evidence for each use.
Why Did SSRIs Replace Tricyclics as the First Choice?
SSRIs didn’t win because they work better. A meta-analysis of 102 trials found no overall difference in effectiveness between SSRIs and TCAs for depression. TCAs may have an edge for people sick enough to need hospital care.
The difference showed up in who kept taking them. In that same analysis, people on SSRIs were less likely to stop treatment because of side effects. That pattern held in the 2018 meta-analysis too, where clomipramine was the only antidepressant with more dropouts than placebo.
Safety in overdose was the other deciding factor, covered below. For most people starting treatment for depression, an SSRI now offers similar benefit with a wider safety margin. Our guide to first-line vs. second-line antidepressants explains how prescribers sequence the options.
When Are Tricyclics Still Used Today?
Tricyclics have kept a place in several specific areas.
Nerve Pain
TCAs remain a first-line choice for neuropathic pain, the burning or electric pain that comes from damaged nerves. A 2015 pain meta-analysis of 229 studies found TCAs had a number needed to treat of 3.6. In plain terms, for roughly every 3 or 4 people treated, one more got at least 50% pain relief than would have on placebo. The authors still rated TCAs lower on tolerability and noted that trial results were modest overall.
Irritable Bowel Syndrome
Low doses can help some people with IBS when first-line treatments haven’t worked. In the 2023 ATLANTIS trial of 463 people in primary care, amitriptyline started at 10 mg and adjusted up to 30 mg improved IBS symptoms more than placebo over 6 months.
Obsessive-Compulsive Disorder
Clomipramine’s strong serotonin action sets it apart for OCD. In two clomipramine trials involving 520 people, OCD symptom scores dropped 38% to 44% over 10 weeks on clomipramine, compared with 3% to 5% on placebo. Our guide to medication for OCD covers how it compares with SSRIs.
Trouble Staying Asleep
Doxepin is the most potent antihistamine in the class, and the 2007 review notes it’s sedating at doses as low as 5 to 25 mg. The AASM insomnia guideline suggests doxepin for sleep maintenance insomnia, which means waking up during the night and struggling to get back to sleep. The guideline rates that recommendation as weak, based on limited evidence.
Depression That Hasn’t Responded
For depression that hasn’t improved on newer medications, a TCA such as nortriptyline is one of several options a psychiatrist may consider. Our guide to treatment-resistant depression options compares the alternatives.
What Side Effects Do Tricyclics Cause?
Most TCA side effects come from receptors they block beyond their main targets. The 2007 review traces them to three main sources:
- Acetylcholine blockade: dry mouth, blurry vision, constipation, trouble urinating, a faster heart rate, and memory problems
- Histamine blockade: drowsiness and weight gain
- Alpha-adrenergic blockade: dizziness or lightheadedness when you stand up quickly
The strength of these effects varies a lot. At doses with similar antidepressant action, nortriptyline has about a tenth of amitriptyline’s anticholinergic effect, which is why it’s often easier to tolerate. Our guide to nortriptyline side effects walks through the heart checks and blood levels that come with it.
There’s also an age factor. In an FDA trial analysis of 372 studies, antidepressants raised the risk of suicidal behavior in adults under 25 compared with placebo, while older adults saw neutral or protective effects. That’s why the first weeks on any antidepressant, including a TCA, call for close follow-up in younger adults.
Why Is a Tricyclic Overdose So Dangerous?
This is the most important safety fact about tricyclics. Too much of a TCA slows the electrical signal that keeps your heartbeat coordinated, which shows up on an ECG as a wider QRS interval. That’s why an overdose can be life-threatening.
The numbers are stark. In a UK overdose study covering 2000 to 2006, a TCA overdose was far more likely to end in death than an SSRI overdose, with case fatality rate ratios of 13.8 for TCAs and 0.5 for SSRIs. A prospective overdose study found that when the heart’s QRS interval widened to 0.10 seconds or more on an ECG, 34% of patients had seizures and 14% had dangerous heart rhythms, while blood drug levels didn’t predict who would.
Don’t wait for symptoms to show up. If you think anyone has taken too much, call 911 immediately. If you’re having thoughts of ending your life, call or text 988 to reach the Suicide and Crisis Lifeline, and ask your prescriber about keeping only a small supply at home.
Who Should Be Careful With Tricyclics?
TCAs aren’t right for everyone. Talk with your prescriber before starting one if any of these apply:
- Heart disease: in a 1998 JAMA trial of 81 people with depression and heart disease, 18% on nortriptyline had serious cardiac events, compared with 2% on the SSRI paroxetine, even though both drugs eased depression similarly.
- Older age: the 2007 review notes that anticholinergic effects can cause confusion and delirium in older adults even at standard doses.
- Trouble urinating, an enlarged prostate, or chronic constipation, which anticholinergic effects can worsen.
- Other medications: some SSRIs slow the liver enzymes that clear TCAs, and combining a TCA with another antidepressant takes expert supervision.
- A history of suicidal thoughts or overdose, given the toxicity above.
Your genes matter too. Some people break down TCAs unusually fast or slow, which can leave blood levels too low to work or high enough to cause toxicity. Our guide to genetic testing for psychiatric medications explains when that testing helps. Pain treatment recommendations advise a screening ECG before starting a TCA, especially after age 40.
How Siggy Fits In
Siggy’s licensed prescribers diagnose and treat the full range of mental health conditions, including depression and anxiety. Siggy’s intake gathers structured information rather than diagnosing you on its own, and a licensed prescriber reviews your full history, including every medication you’ve tried, before anything is prescribed.
That history matters with tricyclics. If you’ve taken a TCA before, how it helped and what side effects you had can shape what makes sense next. The anonymous intake asks for no name, email, or account, and you get a downloadable summary you can share with any clinician, including the doctor managing your pain or sleep.
“When side effects start, you’re on your own until the next appointment.” Medications that need careful monitoring, like TCAs, are where that gap matters most. Siggy isn’t an emergency service. If you may have taken too much of any medication, call 911. This article is for education only and isn’t a substitute for personal medical advice. It reflects sources available as of October 2026.
The Bottom Line on Tricyclic Antidepressants
Tricyclic antidepressants work about as well as SSRIs for depression, but they carry more side effects and a much higher risk in overdose, which is why they moved to second-line status. They still earn a place for nerve pain, IBS, OCD, sleep maintenance, and depression that hasn’t responded to newer options, usually with an ECG, careful dosing, and sometimes blood levels. If you’re comparing medication classes, our guide to the MAOI antidepressant list covers the other older class you may hear about.
Start Your Anonymous Intake
If you or someone you love may have taken too much of a TCA, call 911 first. If you’re weighing antidepressant options, or you’re on a medication that isn’t working the way you hoped, start your anonymous intake. It’s free, there’s no name or email required, and a licensed prescriber reviews your intake before anything is prescribed. Your summary is yours to keep and share with whoever helps you next.
Mental healthcare should stay with you between appointments.
Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.
Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.
Frequently Asked Questions
Are tricyclic antidepressants still prescribed?
Tricyclic antidepressants are still prescribed, though they're rarely the first choice for depression today. Prescribers use them when other antidepressants haven't worked and for specific conditions. Amitriptyline is used for nerve pain and, at low doses, irritable bowel syndrome, clomipramine treats OCD, and low-dose doxepin helps some people stay asleep.
Why are tricyclic antidepressants dangerous in overdose?
Tricyclic antidepressants slow electrical conduction in the heart, so an overdose can cause seizures, dangerous heart rhythms, and death. UK data show a TCA overdose is many times more likely to be fatal than an SSRI overdose. Anyone who may have taken too much needs emergency care right away, even if they seem fine at first.
Is amitriptyline a tricyclic antidepressant?
Amitriptyline is one of the most widely known tricyclic antidepressants. Today it's often prescribed for nerve pain, and at low doses for irritable bowel syndrome, as well as for depression.
Do tricyclic antidepressants cause weight gain?
Tricyclics can cause weight gain because they block histamine receptors, and how strongly a drug blocks them tracks with both weight gain and drowsiness. Doxepin and amitriptyline are among the more sedating options in the class, while nortriptyline tends to cause less drowsiness.
Why do tricyclics help with nerve pain?
Tricyclics are a first-line option for neuropathic pain, the burning or electric pain that comes from damaged nerves. A review of 229 studies found TCAs had one of the best numbers needed to treat among nerve pain medications, though trial results were modest overall and side effects limit them for some people.
Can you take a tricyclic antidepressant with an SSRI?
Sometimes, but only under close medical supervision. Some SSRIs slow the liver enzymes that clear tricyclics, which can push TCA levels into a toxic range, and a pharmacology review concluded that no TCA and SSRI combination is safe to use without expert knowledge. Never combine them on your own.
Sources
- Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet. 2018;391(10128):1357-1366. doi:10.1016/S0140-6736(17)32802-7
- Gillman PK. Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. British Journal of Pharmacology. 2007;151(6):737-748. doi:10.1038/sj.bjp.0707253
- Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. Journal of Affective Disorders. 2000;58(1):19-36. doi:10.1016/S0165-0327(99)00092-0
- Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. The Lancet Neurology. 2015;14(2):162-173. doi:10.1016/S1474-4422(14)70251-0
- Ford AC, Wright-Hughes A, Alderson SL, et al. Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. 2023;402(10414):1773-1785. doi:10.1016/S0140-6736(23)01523-4
- The Clomipramine Collaborative Study Group. Clomipramine in the treatment of patients with obsessive-compulsive disorder. Archives of General Psychiatry. 1991;48(8):730-738. doi:10.1001/archpsyc.1991.01810320054008
- Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2017;13(2):307-349. doi:10.5664/jcsm.6470
- Stone M, Laughren T, Jones ML, et al. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ. 2009;339:b2880. doi:10.1136/bmj.b2880
- Hawton K, Bergen H, Simkin S, et al. Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose. British Journal of Psychiatry. 2010;196(5):354-358. doi:10.1192/bjp.bp.109.070219
- Boehnert MT, Lovejoy FH. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. New England Journal of Medicine. 1985;313(8):474-479. doi:10.1056/NEJM198508223130804
- Roose SP, Laghrissi-Thode F, Kennedy JS, et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA. 1998;279(4):287-291. doi:10.1001/jama.279.4.287
- Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Archives of Neurology. 2003;60(11):1524-1534. doi:10.1001/archneur.60.11.1524